Emily Kearney is a Dubuque, Iowa based counselor who is specialized as Addiction (Substance Use Disorder) Counselor. Her current practice location is 799 Main St, Sutie 110, Dubuque. Patients can book an appointment with her at 563-582-3784.
Emily Kearney is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. She helps her clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.
Complete Profile:
Emily Kearney speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Emily Kearney
Specialization:
Addiction (Substance Use Disorder) Counselor
Gender:
Female
Accepts Medicare Assignment:
No
Practice Address:
799 Main St, Sutie 110, Dubuque, Iowa, 52001-6844
Phone:
563-582-3784
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1235551581
NPI Enumeration Date:
06 Jan, 2014
NPI Last Update On:
06 Jan, 2014
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
799 Main St, Sutie 110 Dubuque, Iowa
Zip:
52001-6844
Phone Number:
563-582-3784
Patients can reach Emily Kearney at 799 Main St, Sutie 110, Dubuque, Iowa or can call to book an appointment on 563-582-3784. *Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.